Literature DB >> 7720764

A population and family study of CYP1A2 using caffeine urinary metabolites.

A Catteau1, Y C Bechtel, N Poisson, P R Bechtel, C Bonaïti-Pellie.   

Abstract

CYP1A2 is a cytochrome P450 which is inducible by polycyclic aromatic hydrocarbons. This induction could be mediated via the Ah locus, which encodes a cytosolic receptor responsible for the regulation of the CYP1A1 gene. Enzyme activity in vivo can be measured by the urinary caffeine metabolite ratio (AFMU + 1X + 1U)/17U. Our goal was to determine, using this ratio, the possible existence of a genetic polymorphism in CYP1A2 induction. For this purpose, a population and family study, including smokers, were undertaken. In a first step, we investigated factors influencing enzyme activity in a population of 245 unrelated individuals. The induction effect of smoking and inhibiting effect of oral contraceptive use were confirmed. None of the other factors examined (age, sex, level of cigarette consumption, nicotine or tar amounts, filter, inhalation) accounted for the interindividual variability in the metabolic ratio. Using the statistical SKUMIX method, a unimodal (one peak) distribution of the ratio was concluded in 164 unrelated smokers, since a second distribution did not significantly improve the fit to the data (chi 2(1) = 1.39, P > 0.2). Segregation analysis was performed on 68 nuclear families and no major gene effect could be shown. Furthermore, the polygenic model did not provide a higher likelihood than the sporadic one, which argues against the existence of any familial resemblance. Although we cannot rule out the possibility that some environmental factors could obscure the phenotypes and occult a genetic determinism, we conclude that genetic factors are probably negligible in the determination of CYP1A2 activity measured by this method.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720764     DOI: 10.1007/bf00196856

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  37 in total

1.  Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise.

Authors:  K Vistisen; S Loft; H E Poulsen
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  Xenobiotic responsive element in the 5'-upstream region of the human P-450c gene.

Authors:  M Kubota; K Sogawa; Y Kaizu; T Sawaya; J Watanabe; K Kawajiri; O Gotoh; Y Fujii-Kuriyama
Journal:  J Biochem       Date:  1991-08       Impact factor: 3.387

Review 3.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

Authors:  F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1991 Jul-Aug       Impact factor: 3.739

4.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

5.  The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.

Authors:  L C Quattrochi; R H Tukey
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

6.  Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse.

Authors:  D W Nebert; F M Goujon; J E Gielen
Journal:  Nat New Biol       Date:  1972-03-29

7.  Variability in caffeine metabolism.

Authors:  D M Grant; B K Tang; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

8.  A urinary metabolite ratio that reflects systemic caffeine clearance.

Authors:  M E Campbell; S P Spielberg; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1987-08       Impact factor: 6.875

9.  Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor.

Authors:  H Reyes; S Reisz-Porszasz; O Hankinson
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

10.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

Authors:  T Shimada; M Iwasaki; M V Martin; F P Guengerich
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

View more
  7 in total

1.  Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda.

Authors:  L Christiansen; A Bygum; A Jensen; K Thomsen; F Brandrup; M Hørder; N E Petersen
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

Review 2.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

3.  The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.

Authors:  M R Welfare; M F Bassendine; A K Daly
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

4.  Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.

Authors:  C Sachse; J Brockmöller; S Bauer; I Roots
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

5.  Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.

Authors:  D S Ou-Yang; S L Huang; W Wang; H G Xie; Z H Xu; Y Shu; H H Zhou
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

6.  Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.

Authors:  N Rizzo; C Padoin; S Palombo; J M Scherrmann; C Girre
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.